Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

U.S. Pharmacopeia Moves Melamine Testing Into The 21st Century

This article was originally published in The Tan Sheet

Executive Summary

U.S. Pharmacopeia is developing a protein testing method that cannot be "tricked" by contaminants such as melamine, unlike the existing standard for analysis
Advertisement

Related Content

Monograph Modernization Initiative Looks To Close OTC Quality Loopholes
Monograph Modernization Initiative Looks To Close OTC Quality Loopholes
Monograph Modernization Initiative Looks To Close OTC Quality Loopholes
China Issues Revised GMP Draft; Compliance Expected In Stages
China Issues Revised GMP Draft; Compliance Expected In Stages
Adulteration meeting set
FDA Seeks Public Input On Secrets Of Profit-Motivated Adulteration
Melamine In U.S. Could Pose More Risk To Food Safety Regime Than Infants
Melamine In U.S. Could Pose More Risk To Food Safety Regime Than Infants
FDA Global Supply Chain Concerns Prompt Glycerin DEG Testing Guidance

Topics

Advertisement
UsernamePublicRestriction

Register

PS102623

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel